Pricing Log in Create free account
Friday 6 November 2026 Export MANE’s income statement to Excel — free account

Veradermics Incorporated

MANE Healthcare Biotechnology

138.19 9.59 +7.46%
Market cap
$5.4B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Veradermics Incorporated 8-K filed Feb 5, 2026

Period ended Feb 5, 2026 · Filed · accepted 4:21 PM ET · Document on sec.gov · Filing index

5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits

Nothing in this filing raised a red flag, and we have no summary of it. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov